Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis (Q34585467)

3 August 2017

5 references

22 June 2019

6 August 2019

17 September 2019

11 September 2020

5 December 2020

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis (English)

1 reference

pharmaceutical preparation

3 August 2017

2 references

22 June 2019

6 August 2019

1 reference

PubMed

6 August 2019

heterocyclic compound

1 reference

17 September 2019

1 reference

11 September 2020

1 reference

5 December 2020

PierAchille Santus

4

0 references

Stefano Aliberti

object named as

Stefano Aliberti

2

0 references

Francesco Blasi

object named as

Francesco Blasi

1

0 references

author name string

Paolo Tarsia

3

1 reference

3 August 2017

Stefano Centanni

5

1 reference

3 August 2017

Luigi Allegra

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

3 August 2017

6 references

3 August 2017

22 June 2019

6 August 2019

17 September 2019

11 September 2020

5 December 2020

2

1 reference

3 August 2017

1

1 reference

3 August 2017

27-31

1 reference

Prulifloxacin: a new antibacterial fluoroquinolone

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Penetration of orally administered prulifloxacin into human lung tissue

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Pharmacologic characteristics of prulifloxacin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Pharmacokinetics and Tolerability of Prulifloxacin after Single Oral Administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Infectious etiology of acute exacerbations of chronic bronchitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Acute exacerbations of chronic bronchitis: an international comparison

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Chlamydia pneumoniae infection in acute exacerbations of COPD.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

In vivo evaluation of NM441, a new thiazeto-quinoline derivative

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692114

Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function

27 October 2018

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2007.2.1.27

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2007.2.1.27

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2007.2.1.27

Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2007.2.1.27

Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF 3013 against Klebsiella pneumoniae

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/COPD.2007.2.1.27

1 reference

3 August 2017

1 reference

3 August 2017

1 reference